Stephen W. Potter - 21 Aug 2022 Form 4 Insider Report for APPLIED GENETIC TECHNOLOGIES CORP

Role
Chief Business Officer
Signature
/s/ Stacie Aarestad, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
21 Aug 2022
Net transactions value
$0
Form type
4
Filing time
24 Aug 2022, 20:11:52 UTC
Previous filing
01 Jul 2022
Next filing
01 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGTC Stock Option (right to buy) Award $0 +133,100 $0.000000 133,100 21 Aug 2022 Common Stock 133,100 $0.4000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option becomes exercisable in equal monthly installments over four years from the date of grant.